International Clinical Trial: A study to test whether a nasal antibody spray can help reduce flu infection in healthy adults, using a controlled research setting where volunteers are exposed to flu under medical supervision

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN85449588) titled 'A study to test whether a nasal antibody spray can help reduce flu infection in healthy adults, using a controlled research setting where volunteers are exposed to flu under medical supervision' on July 31.

Study Type: Interventional

Study Design: Allocation: Randomized controlled trial Masking: Blinded (masking used) Control: Placebo Assignment: Parallel Purpose: Prophylaxis

Primary Sponsor: Leyden Laboratories B.V.

Condition: Healthy volunteers. Intended indication for CR9114 monoclonal antibody under development: prevention (prophylaxis) of influenza A and B infections in adults. Infections and Infestations...